Sensex, Nifty slide to 3-month lows as ₹9.86 lakh crore evaporates — what traders are watching now
20 January 2026
1 min read

Sensex, Nifty slide to 3-month lows as ₹9.86 lakh crore evaporates — what traders are watching now

Mumbai, Jan 20, 2026, 21:48 IST

  • Sensex slipped 1,065.71 points, closing at 82,180.47, while Nifty 50 declined 1.38% to finish at 25,232.50
  • BSE-listed stocks lost roughly ₹9.86 lakh crore (₹9.86 trillion) in market value during the session
  • Hundreds of shares plunged to new 52-week lows as analysts pointed to critical support levels between 25,150 and 25,080 on the Nifty.

Indian equities dropped sharply on Tuesday, with the Sensex and Nifty 50 marking their lowest finishes in over three months. The selloff erased roughly 9.86 lakh crore rupees in market value from companies listed on the BSE. The Sensex closed 1.28% lower at 82,180.47, while the Nifty 50 slipped 1.38% to 25,232.50. 1

The decline is significant now—it’s moved beyond a simple large-cap hiccup. Foreign selling and a patchy earnings season are dragging the broader market lower, while investors watch closely to see how much domestic buying can soak up the selling pressure.

Trade-war chatter is now routine in the daily tape. The Times of India connected the decline to U.S. tariff threats and steady foreign outflows, coupled with disappointing corporate earnings and a cautious market mood.

Breadth turned ugly. Over 490 stocks on the NSE hit 52-week lows, Upstox reported — including names like IRCTC, Patanjali Foods, Kaynes Technology, Havells India, and Tejas Networks. India VIX, the market’s volatility gauge, climbed 4.6% to 12.37, signaling rising stress. 2

Foreign Institutional Investors (FIIs), also known as overseas funds, kept selling, with domestic institutions snapping up shares, Upstox reported earlier. This trend has heightened daily volatility and squeezed tolerance for earnings disappointments.

Moneycontrol reported the Sensex plunged as much as 1,235.6 points during the session, while the Nifty recorded its sharpest single-day drop since April 7, 2025, closing at levels not seen since October 15, 2025. Realty, auto, and IT stocks were among the biggest losers. Meanwhile, midcap and smallcap indexes slipped by up to 3%, according to the report. 3

Ajit Mishra, senior vice president (research) at Religare Broking, noted that the Nifty is hovering near its 200 DEMA — a key long-term moving average — at about 25,150. “A brief pause or rebound cannot be ruled out,” he added.

SBI Securities’ Sudeep Shah noted the daily RSI, a momentum indicator signaling “oversold” levels, dropped to 29.27—its lowest since March 2025. He cautioned that if the index breaks below 25,080, it might fall further toward 24,900.

The risk is straightforward: if long-term support breaks, selling could spiral. It gets trickier if foreign outflows continue and tariff rhetoric intensifies, forcing domestic buyers to shoulder more of the burden.

So far, any rebound must break through the immediate ceiling. Analysts pointed to the 25,400–25,600 range on the Nifty as the closest resistance, with the direction of banking and IT stocks likely to determine if the relief holds or fizzles out.

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Palantir stock dips despite Hyundai expansion as Reuters sources peg deal in “hundreds of millions”
Previous Story

Palantir stock dips despite Hyundai expansion as Reuters sources peg deal in “hundreds of millions”

Constellation Energy stock slips after Wells Fargo trims target as PJM data-center rules loom
Next Story

Constellation Energy stock slips after Wells Fargo trims target as PJM data-center rules loom

Go toTop